PACK IN HAND · ONE-PAGE CHECK
Medicine pack check sheet
Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.
Published record starting point
- Record display name
- CREXONT
- Generic name / active ingredient
- carbidopa and levodopa extended-release capsules
- Dosage-form class
- Carbidopa/levodopa fixed two-ingredient extended-release oral capsules: 35/140, 52.5/210, 70/280 and 87.5/350 mg. Each pair states the two ingredients in one capsule. CREXONT, RYTARY, SINEMET and STALEVO are distinct products, and label numbers are not an individual conversion table.
- Route
- Oral
- Record reviewed
- 2026-08-29
Copy from the pack in hand
Source-linked reading points
- Swallow whole; do not chew, divide or crush. For swallowing difficulty, the label allows opening one complete capsule, sprinkling all contents on 1–2 tablespoons of applesauce and swallowing immediately without chewing. Do not store or take only part. Do not take with alcohol.
- Immediate-release carbidopa/levodopa is not self-substitutable 1:1. The label contains professional conversion tables and clinician-facing information describing an approximately 1:1 levodopa-component transition from RYTARY, but this is not a consumer conversion rule. Do not copy tables, calculate capsules, combine old supplies or alternate products by day.
- Use with other levodopa products has not been studied, and stopping a COMT inhibitor may alter treatment needs. Do not self-add, reduce, combine, switch or rapidly stop. Use local emergency services for high fever, marked rigidity, altered consciousness or autonomic instability after a rapid reduction or withdrawal.
- Sudden sleep, marked somnolence, dizziness, hallucinations, psychotic symptoms, intense urges or new involuntary movements require prompt contact with the treating team. Professional assessment is especially important before driving or operating machinery. Family or carers may notice changes earlier.
Reviewed presentation examples — compare every field
- Carbidopa 35 mg plus levodopa 140 mg per capsule; carton containing a 120-capsule bottleNDC 64896-967-16
- Carbidopa 35 mg plus levodopa 140 mg per capsule; carton containing a 120-capsule bottleNDC 64896-967-23
- Carbidopa 52.5 mg plus levodopa 210 mg per capsule; carton containing a 120-capsule bottleNDC 64896-968-16
- Carbidopa 52.5 mg plus levodopa 210 mg per capsule; carton containing a 120-capsule bottleNDC 64896-968-23
- Carbidopa 70 mg plus levodopa 280 mg per capsule; carton containing a 120-capsule bottleNDC 64896-969-16
- Carbidopa 70 mg plus levodopa 280 mg per capsule; carton containing a 120-capsule bottleNDC 64896-969-23
- Carbidopa 87.5 mg plus levodopa 350 mg per capsule; carton containing a 120-capsule bottleNDC 64896-970-16
- Carbidopa 87.5 mg plus levodopa 350 mg per capsule; carton containing a 120-capsule bottleNDC 64896-970-23